[1] |
Cecconi M,Evans L,Levy M,et al. Sepsis and septic shock[J]. Lancet,2018,392(10141): 75-87. doi: 10.1016/S0140-6736(18)30696-2
|
[2] |
Rudd KE,Johnson SC,Agesa KM,et al. Global,regional,and national sepsis incidence and mortality,1990-2017:analysis for the Global Burden of Disease Study[J]. Lancet,2020,395(10219): 200-211. doi: 10.1016/S0140-6736(19)32989-7
|
[3] |
Gupta A,Khanna S. Fecal microbiota transplantation[J]. JAMA,2017,318(1): 102. doi: 10.1001/jama.2017.6466
|
[4] |
Hvas CL,Dahl Jørgensen SM,Jørgensen SP,et al. Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection[J]. Gastroenterology,2019,156(5): 1324-1332. doi: 10.1053/j.gastro.2018.12.019
|
[5] |
Papanicolas LE,Gordon DL,Wesselingh SL,et al. Improving risk-benefit in faecal transplantation through microbiome screening[J]. Trends Microbiol,2020,28(5): 331-339. doi: 10.1016/j.tim.2019.12.009
|
[6] |
Wurm P,Spindelboeck W,Krause R,et al. Antibiotic-associated apoptotic enterocolitis in the absence of a defined pathogen:the role of intestinal microbiota depletion[J]. Crit Care Med,2017,45(6): e600-e606. doi: 10.1097/CCM.0000000000002310
|
[7] |
Kim SM,DeFazio JR,Hyoju SK,et al. Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity[J]. Nat Commun,2020,11(1): 2354. doi: 10.1038/s41467-020-15545-w
|
[8] |
Gai XW,Wang HW,Li YQ,et al. Fecal microbiota transplantation protects the intestinal mucosal barrier by reconstructing the gut microbiota in a murine model of Sepsis[J]. Front Cell Infect Microbiol,2021,11: 736204. doi: 10.3389/fcimb.2021.736204
|
[9] |
National Institute of Hospital Administration N,Society of Parenteral and Enteral Nutrition CMA,Chinese Society for Parenteral and Enteral Nutrition Intestinal Microecology Cooperative Group. Expert consensus on clinical application management of fecal microbiota transplantation (2022 edition)[J]. Zhonghua Wei Chang Wai Ke Za Zhi,2022,25(9): 747-756.
|
[10] |
Li N,Wang W,Zhou H,et al. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury[J]. Free Radic Biol Med,2020,160: 303-318. doi: 10.1016/j.freeradbiomed.2020.08.009
|
[11] |
Napier BA,Andres-Terre M,Massis LM,et al. Western diet regulates immune status and the response to LPS-driven sepsis independent of diet-associated microbiome[J]. Proc Natl Acad Sci U S A,2019,116(9): 3688-3694. doi: 10.1073/pnas.1814273116
|
[12] |
Gong SH,Yan ZZ,Liu ZG,et al. Intestinal microbiota mediates the susceptibility to polymicrobial Sepsis-induced liver injury by granisetron generation in mice[J]. Hepatology,2019,69(4): 1751-1767. doi: 10.1002/hep.30361
|
[13] |
Hosokawa K,Obara H,Fukuda K,et al. Specificity of presepsin as a biomarker of bacterial infection in mouse Sepsis models[J]. J Surg Res,2023,283: 572-580. doi: 10.1016/j.jss.2022.10.063
|
[14] |
Zhou L,Zhou WQ,Joseph AM,et al. Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation[J]. Nat Immunol,2022,23(2): 251-261. doi: 10.1038/s41590-021-01110-0
|
[15] |
Guo L,Shen SK,Rowley JW,et al. Platelet MHC class I mediates CD8 + T-cell suppression during sepsis[J]. Blood,2021,138(5): 401-416. doi: 10.1182/blood.2020008958
|
[16] |
Adelman MW,Woodworth MH,Langelier C,et al. The gut microbiome’s role in the development,maintenance,and outcomes of sepsis[J]. Crit Care,2020,24(1): 278. doi: 10.1186/s13054-020-02989-1
|
[17] |
He WX,Xiao K,Xu JR,et al. Recurrent Sepsis exacerbates CD4 + T cell exhaustion and decreases antiviral immune responses[J]. Front Immunol,2021,12: 627435. doi: 10.3389/fimmu.2021.627435
|
[18] |
Gaudino SJ,Kumar P. Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis,bacterial infections,and tumorigenesis[J]. Front Immunol,2019,10: 360. doi: 10.3389/fimmu.2019.00360
|
[19] |
李晓明,刘超,王晓莉,等. 基于炎性标志物构建ICU脓毒症患者早期预测模型[J]. 解放军医学院学报,2022,43(4): 400-405 + 441. doi: 10.3969/j.issn.2095-5227.2022.04.006
|
[20] |
Haak BW,Wiersinga WJ. The role of the gut microbiota in sepsis[J]. Lancet Gastroenterol Hepatol,2017,2(2): 135-143. doi: 10.1016/S2468-1253(16)30119-4
|
[21] |
Bu Y,Wang H,Ma X,et al. Untargeted metabolomic profiling of the correlation between prognosis differences and PD-1 expression in Sepsis:a preliminary study[J]. Front Immunol,2021,12: 594270. doi: 10.3389/fimmu.2021.594270
|
[22] |
Sun YN,Xie JF,Anyalebechi JC,et al. CD28 agonism improves survival in immunologically experienced septic mice via IL-10 released by Foxp3 + regulatory T cells[J]. J Immunol,2020,205(12): 3358-3371. doi: 10.4049/jimmunol.2000595
|
[23] |
Venet F,Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression[J]. Nat Rev Nephrol,2018,14(2): 121-137. doi: 10.1038/nrneph.2017.165
|
[24] |
徐建桥,解立新. 脓毒症患者免疫失衡相关分子标记物的临床意义综述[J]. 解放军医学院学报,2017,38(6): 593-595. doi: 10.3969/j.issn.2095-5227.2017.06.029
|